Artwork

Content provided by Ladan Jiracek. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ladan Jiracek or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Suraj Mudichintala on investing in bioelectronic medicine companies with Action Potential Venture

29:18
 
Share
 

Manage episode 359131309 series 2968631
Content provided by Ladan Jiracek. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ladan Jiracek or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Suraj Mudichintala is a Senior Associate at Action Potential Capital which is GSK's bioelectronic medicine venture fund.

Top 3 Takeaways:

  • "Our fund is different in that we invest actually directly off of GSK's balance sheet. So we're what's called an evergreen fund where we don't actually have a fund size"
  • "The way that I think about it is that a VC is really paid to allocate capital but really is really paid to think. You really have to think about what is the next space or the next technology that could disrupt a space? And because of that, it's a much you often have to take a much more longitudinal view. And it takes a lot of patience and tracking a space oftentimes for years"
  • "When you reach out to a VC having a pitch, first of all, sending a non-confidential pitch deck is mandatory, I think. And that deck is essentially where we're making the first decision as to whether or not to do a call with you"

0:45 Do you want to introduce yourself better than I just did?

1:15 "Do you wanna talk about Action Potential, what it is, who it was formed by, and the investment thesis?"

2:30 Do you want to talk about the expansion of the AP investment thesis?

4:30 What does traditional Venture Capital look like and how is it different in that you are funded by GSK?

6:15 What do the positions within a VC firm look like?

7:45 How has it been for you going from Analyst to Associate?

8:45 What does your due diligence look like?

11:45 "A lot of VCs have a target size range, be it seed or angel or, maybe larger institutional stuff. But it sounds like you guys don't really have that?"

12:45 "How did you get into this space?"

14:45 "So how does consulting compare to the VC life?"

18:45 "What would you suggest is the best way to get your attention?"

24:00 What are some tips and tricks to reaching out to you?

27:00 What was the worst pitch deck you ever saw?

28:30 " Is there anything that we didn't talk about that you wanted to mention?"

  continue reading

251 episodes

Artwork
iconShare
 
Manage episode 359131309 series 2968631
Content provided by Ladan Jiracek. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ladan Jiracek or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Suraj Mudichintala is a Senior Associate at Action Potential Capital which is GSK's bioelectronic medicine venture fund.

Top 3 Takeaways:

  • "Our fund is different in that we invest actually directly off of GSK's balance sheet. So we're what's called an evergreen fund where we don't actually have a fund size"
  • "The way that I think about it is that a VC is really paid to allocate capital but really is really paid to think. You really have to think about what is the next space or the next technology that could disrupt a space? And because of that, it's a much you often have to take a much more longitudinal view. And it takes a lot of patience and tracking a space oftentimes for years"
  • "When you reach out to a VC having a pitch, first of all, sending a non-confidential pitch deck is mandatory, I think. And that deck is essentially where we're making the first decision as to whether or not to do a call with you"

0:45 Do you want to introduce yourself better than I just did?

1:15 "Do you wanna talk about Action Potential, what it is, who it was formed by, and the investment thesis?"

2:30 Do you want to talk about the expansion of the AP investment thesis?

4:30 What does traditional Venture Capital look like and how is it different in that you are funded by GSK?

6:15 What do the positions within a VC firm look like?

7:45 How has it been for you going from Analyst to Associate?

8:45 What does your due diligence look like?

11:45 "A lot of VCs have a target size range, be it seed or angel or, maybe larger institutional stuff. But it sounds like you guys don't really have that?"

12:45 "How did you get into this space?"

14:45 "So how does consulting compare to the VC life?"

18:45 "What would you suggest is the best way to get your attention?"

24:00 What are some tips and tricks to reaching out to you?

27:00 What was the worst pitch deck you ever saw?

28:30 " Is there anything that we didn't talk about that you wanted to mention?"

  continue reading

251 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play